ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 지혈 제품 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 예측기간의 성장은 저침습수술 수요 증가, 세계 외상 증례 증가, 만성질환에서의 지혈 용도 확대, 외래수술센터(ASC)로의 전환, 맞춤형 의료, 바이오마커 연구에 기인한다고 생각됩니다. 예측 기간에 있어서의 주요한 동향으로서는 지혈의 기술 혁신, 지혈 기술의 진보, 저침습 수술에 대한 기호 상승, 만성 질환의 이환율 증가, 생분해성 지혈제에 대한 주목 등을 들 수 있습니다.
혈액 질환의 유병률 증가는 향후 지혈 제품 시장의 성장을 견인할 것으로 예측됩니다. 지혈 제품은 신체의 응고 및 출혈 과정을 관리하는 데 도움이되며 다양한 혈액 장애에서 발생할 수있는 과다 출혈(출혈)과 과잉 응고(혈전증)을 모두 다루기 위해서, 다양한 혈액장애에서 이용되고 있습니다. 예를 들어, 미국에 기반을 둔 Leukemia and Lymphoma Society는 2022년 미국 백혈병 진단율이 2021년 시민 10만명당 14.1명에서 2022년에는 14.3명으로 상승했다고 보고하고 있습니다. 그 결과, 혈액 질환의 유병률 증가가 지혈 제품 시장의 성장에 박차를 가하고 있습니다.
심장 질환의 유병률 증가는 지혈 제품 시장의 성장을 가속할 것으로 예상됩니다. 관련 출혈 관리, 예방 및 치료에 중요한 역할을 수행합니다. 이 제품은 출혈을 최소화 할 수 있으므로 수혈의 필요성을 줄이고 심장 질환에서 병증을 완화할 수 있습니다. 예를 들어 2024년 4월, 미국에 기반을 둔 비영리단체인 미국심장협회는 심혈관질환으로 인한 연령조정사망률이 2024년 10만명 당 233.3명으로 상승하여 2023년 10만 명당 224.4명에서 4.0% 증가했다고 보고했으며, 따라서 심장 질환의 유병률 증가가 향후 지혈제품 시장의 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 지혈 제품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계 지혈 제품 시장 : 성장률 분석
세계 지혈 제품 시장 실적 : 규모와 성장, 2019-2024
세계 지혈 제품 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계 지혈 제품 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 지혈 제품 시장 : 제품별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
국소 지혈 제품
수액 지혈 제품
고급 지혈 제품
세계의 지혈 제품 시장 : 용도별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
외상
수술
혈우병
심근경색
기타 용도
세계 지혈 제품 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
클리닉
기타 최종 사용자
세계의 지혈 제품 시장 : 국소 지혈 제품 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
지혈제
조직 실란트
피브린 실란트
세계의 지혈 제품 시장 : 수액 지혈 제품 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
다혈소판 혈장(PRP)
응고 인자
프로트롬빈 복합체 농축물
세계의 지혈 제품 시장 : 고? 지혈 제품 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
생물학적 접착제
합성 지혈제
지혈 붕대
제7장 지역별 및 국가별 분석
세계의 지혈 제품 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 지혈 제품 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
지혈 제품 시장 : 경쟁 구도
지혈 제품 시장 : 기업 프로파일
Pfizer Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
Abbott Laboratories : 개요, 상품 및 서비스, 전략 및 재무분석
Thermo Fisher Scientific Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
Medtronic plc : 개요, 상품 및 서비스, 전략 및 재무분석
Johnson And Johnson Pvt. Ltd. : 개요, 상품 및 서비스, 전략 및 재무분석
제31장 기타 주요 기업 및 혁신 기업
Siemens Healthineers
Becton Dickinson and Company(BD)
Stryker Corporation
Baxter International Inc.
Boston Scientific Corporation
F. Hoffmann-La Roche Ltd.
BBraun Melsungen AG
Fresenius Kabi AG
Zimmer Biomet Holdings Inc.
Olympus Corporation
Grifols SA
Terumo BCT Inc.
Smith And Nephew plc
Ethicon Suture Laboratories
Hologic Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
지혈 제품 시장(2029년) : 새로운 기회를 제공하는 국가
지혈 제품 시장(2029년) : 새로운 기회를 제공하는 부문
지혈 제품 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Hemostasis products are medical substances or devices employed to control bleeding and facilitate clotting (hemostasis) across diverse medical contexts. These products play a critical role in the management of bleeding disorders, promotion of wound healing, and ensuring the proper functioning of the body's clotting mechanisms.
The primary categories of hemostasis products include topical hemostasis products, infusible hemostasis products, and advanced hemostasis products. Topical hemostasis products encompass medical substances or materials specifically designed to halt or regulate bleeding. They find applications in various scenarios such as trauma, surgery, hemophilia, myocardial infarction, and others, with major end-users including hospitals, clinics, and others.
The hemostasis products market research report is one of a series of new reports from The Business Research Company that provides hemostasis products market statistics, including hemostasis products industry global market size, regional shares, competitors with a hemostasis products market share, detailed hemostasis products market segments, market trends and opportunities, and any further data you may need to thrive in the hemostasis products industry. This hemostasis products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemostasis products market size has grown strongly in recent years. It will grow from $1.7 billion in 2024 to $1.81 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in surgical procedures, growing aging population, increasing incidence of hemophilia, expanding healthcare infrastructure, rising awareness about blood clotting disorders.
The hemostasis products market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for minimally invasive surgeries, global increase in trauma cases, expansion of hemostasis applications in chronic diseases, shift towards ambulatory surgical centers, personalized medicine and biomarker research. Major trends in the forecast period include technological innovations in hemostasis, advancements in hemostatic technologies, rising preference for minimally invasive procedures, growing incidence of chronic diseases, focus on biodegradable hemostatic agents.
The growing prevalence of blood disorders is anticipated to drive the growth of the hemostasis products market in the future. Blood disorders, also referred to as hematologic disorders, encompass a range of medical conditions that impact the composition, function, and behavior of blood and its components. Hemostasis products are utilized in various blood disorders to help manage the processes of clotting and bleeding in the body, addressing both excessive bleeding (hemorrhage) and excessive clotting (thrombosis) that can arise in different blood disorders. For example, in 2022, the Leukemia and Lymphoma Society, a U.S.-based organization, reported that the rate of leukemia diagnoses in the United States rose from 14.1 per 100,000 citizens in 2021 to 14.3 per 100,000 in 2022. Consequently, the increasing prevalence of blood disorders is fueling the growth of the hemostasis products market.
The rising prevalence of cardiac disorders is expected to propel the growth of the hemostasis products market moving forward. Cardiac disorders encompass a wide range of medical conditions and diseases that impact the heart and blood vessels. Hemostasis products play a critical role in managing bleeding related to cardiac disorders, as well as in their prevention and treatment. These products can help minimize blood loss, thereby reducing the need for blood transfusions and the associated complications in cardiac disorders. For instance, in January 2024, the American Heart Association, a U.S.-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, reflecting a 4.0% increase from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiac disorders is contributing to the growth of the hemostasis products market going forward.
Major companies in the hemostasis products market are focusing on the development of innovative drugs, including the Nexpowder endoscopic hemostasis system, and obtaining approvals for a comprehensive range of active and passive hemostatic products for bleeding control. The endoscopic hemostasis system is a medical device and technique used to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. Medtronic plc, a US-based medical device company, received clearance from the U.S. Food and Drug Administration in September 2022 for the Nexpowder Endoscopic Hemostasis System, designed for the treatment of nonvariceal upper GI bleeding. This innovative hemostatic product has the potential to make a significant impact on the treatment of nonvariceal upper GI bleeding due to its ease of use, effectiveness, and good tolerability.
In March 2022, C2Dx Inc., a U.S.-based specialty medical devices company, acquired Hemostatix Medical Technologies LLC for an undisclosed sum. This acquisition supports C2Dx's strategy to invest in and enhance the delivery of valuable niche products, facilitating the integration of the thermal scalpel system under the C2Dx brand. Hemostatix Medical Technologies LLC is also a U.S.-based medical technology company.
Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic PLC, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew PLC, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV
North America was the largest region in the hemostasis products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the hemostasis products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hemostasis products market consists of sales of hemostatic agents, hemostatic powders, hemostatic sponges, collagen, oxidized regenerated cellulose, gelatin, polysaccharide, flowable complex, thrombin complex, fibrin complex, synthetic sealants, and fresh frozen plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemostasis Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hemostasis products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hemostasis products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostasis products market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Hemostasis Products Market Characteristics
3. Hemostasis Products Market Trends And Strategies
4. Hemostasis Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Hemostasis Products Growth Analysis And Strategic Analysis Framework
5.1. Global Hemostasis Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hemostasis Products Market Growth Rate Analysis
5.4. Global Hemostasis Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hemostasis Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hemostasis Products Total Addressable Market (TAM)
6. Hemostasis Products Market Segmentation
6.1. Global Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Hemostasis Product
Infusible Hemostasis Product
Advanced Hemostasis Product
6.2. Global Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trauma
Surgery
Hemophilia
Myocardial Infarction
Other Applications
6.3. Global Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End Users
6.4. Global Hemostasis Products Market, Sub-Segmentation Of Topical Hemostasis Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hemostatic Agents
Tissue Sealants
Fibrin Sealants
6.5. Global Hemostasis Products Market, Sub-Segmentation Of Infusible Hemostasis Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Platelet-Rich Plasma (PRP)
Coagulation Factors
Prothrombin Complex Concentrates
6.6. Global Hemostasis Products Market, Sub-Segmentation Of Advanced Hemostasis Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biological Adhesives
Synthetic Hemostatic Agents
Hemostatic Dressings
7. Hemostasis Products Market Regional And Country Analysis
7.1. Global Hemostasis Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hemostasis Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
